Exercise as a physiotherapy potentiExercise as a physiotherapy potentiates thermogenesis and obesity management through elevation of myokine "irisin"ates thermogenesis and obesity management through elevation of myokine "irisin"
DOI:
https://doi.org/10.56511/JIPBS.2018.v5.i04.pp74-80Abstract
The present study was designed to study the possible effect of exercise on serum irisin level in both healthy and obese rats and also, to explore the relations between irisin and some atherogenic risk factors. The obtained data revealed significant increases in serum levels of irisin and FT4 in both healthy and obese groups in response to exercise, while FT3 values showed insignificant change. Also, a significant increase in serum irisin and a significant decrease in FT4 were observed obese group compared to normal group. Exercise significantly improved lipid profile, glucose, insulin level and HOMA-IR that rose in obese group. In conclusion, irisin was found to increase after moderate intensity exercise training; therefore, irisin could be a potential therapeutic target for human metabolic diseases and other disorders that are improved with exercise.
Keywords:
Obesity, irisin, thyroid hormones, exercise, ratsDownloads
References
Ditschuneit HH, Flechtner-Mors M, Johnson TD, Adler G. Metabolic and Weight-Loss Effects of a Long-Term Dietary Intervention in Obese Patients. The American Journal of Clinical Nutrition 1999; 69 (2):198 – 204.
Lechleitner M. Pathogenesis of Obesity. Wiener Medizinische Wochenschrift 2004; 154 (13-14): 300 – 304.
Delzenne NM, Cani PD. A Place for dietary fibre in the management of the metabolic syndrome. Current Opinion in Clinical Nutrition and Metabolic Care 2005; 8(6): 636 – 640.
Nocon M, Hiemann T, Müller-Riemenschneider F, Thalau F, Roll S, Willich SN. Association of physical activity with all-cause and cardiovascular mortality: A Systematic review and meta-analysis. European Journal of Cardiovascular Prevention and Rehabilitation 2008; 15(3): 239 – 246.
Fletcher GF, Balady G, Blair SN, Blumenthal J, Caspersen C, Chaitman B, Epstein S, SivarajanFroelicher ES, Froelicher VF, Pina IL, Pollock ML.Statement on exercise: benefits and recommendations for physicalactivityprograms for all Americans. A statement for healthprofessionals by the Committee on Exercise and CardiacRehabilitation of the Council on Clinical Cardiology, American Heart Association. Circulation 1996; 94 (4): 857 – 862.
Pedersen BK. Muscles and their myokines. The Journal of Experimental Biology 2011; 214(2): 337 – 346.
Pratesi A, Tarantini F, Di Bari M. Skeletal Muscle: An Endocrine Organ. Clinical Cases in Mineral and Bone Metabolism 2013; 10(1):11 – 14.
Raschke S, Eckel J.Adipo-myokines: twosides of the samecoin--mediators of inflammation and mediators of exercise. Mediators of Inflammation 2013; 320724: 1-16.
Damen S, Janzadeh A, Yousefifard M, Nasirinezhad F. The Effect of intrathecal injection of irisin on pain threshold and expression rate of GABAB receptors in peripheral neuropathic pain model. J Chem Neuroanal 2018; 91:17-26.
Boström P, Jun W, Mark PJ, Anisha K, Li Y, James CL, Kyle AR. A PGC1- α -dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012; 481(7382): 463 – 468.
Norheim F, Langleite TM, Hjorth M, Holen T, Kielland A, Stadheim HK, Gulseth HL, Birkeland KI, Jense J, Drevon CA. The effects of acute and chronicexercise on PGC-1 α , irisin and browning of subcutaneous adipose tissue in humans. The FEBS Journal 2014; 281(3): 739 – 749.
Sanchis-Gomar F, Lippi G, Perez Q, Mayero S. A new potential hormonal target for the treatment of obesity and type 2 diabetes, J. Diabetes 2012; 63:183-193.
Czarkowska-Paczek B, Zendzian-Piotrowska M, Gala K, Sobol M, Paczek L. One session of exercise or endurance training does not influence serum levels of irisin in rats. Journal of Physiology and Pharmacology 2014; 65 (3): 449 – 454.
Noeman SA, Hamooda HE, Baalash AA. Biochemical study of oxidative stress markers in the liver, kidney and heart of high fat diet induced obesity in rats. Diabetology & Metabolic Syndrome 2011; 3(1): 3:17.
Lapmanee S, Charoenphandhu N, Krishnamra N, Charoenphandhu J. Anxiolytic-like actions of reboxetine, venlafaxine and endurance swimming in stressed male rats. Behavioural Brain Research 2012; 231(1): 20 – 28.
Teixeira de Lemos E, Reis F, Baptista S, Pinto R, Sepodes B, Vala H, Rocha-Pereira P. Exercise training decreases proinflammatory profile in zucker diabetic (Type 2) fatty rats. Nutrition 2009; 25(3): 330 – 339
Novelli EL, Diniz YS, Galhardi CM, Ebaid GM, Rodriguez HG, Mani F, Fernandes AA, Cicogna AC, Novelli F. Anthropometrical parameters and markers of obesity in rats. Laboratory Animals 2007; 41(1): 111 – 119.
Sun J, Zhang C, Kim M, Su Y, Qin L, Dong J, Zhou Y, Ding S. Early potential effects of resveratrol supplementation on skeletal muscle adaptation involved in exercise-induced weight loss in obese mice. BMB Rep 2018; 51(4):200-205.
Steel RG, Torrie GH. Principles and Procedures of Statistics: A Biometrical Approach. New York: McGraw Hill 1980; 633.
Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, Schneider BE, Mantzoros CS. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism 2012; 61(12): 1725 – 1738.
Timmon JA, Baar K, Davidsen PK, Atherton PJ. Is irisin a human exercise gene?. Nature 2012; 488 (7413): E9 – 10.
Kazeminasab F, Marandi SM, Ghaedi K, Safaeinejad Z, Esfarjani F, NasrEsfahani MH. A comparative study on the effects of high-fat diet and endurance training on the PGC-1 α -FNDC5/irisin pathway in obese and non-obese male C57BL/6 mice. Appl. Physiol. Nutr. Metab. 2018; 43(7):651-662.
Besse-Patin A, Montastie E, Vinel C, Castan-Laurell I, Louche K, Dray C, Daviaud D, Mir L, Marques MA, Thalamas C, Valet P, Langin D, Moro C, Viguerie N. Effect of endurance training on skeletal muscle myokine expression in obese men: identification of apelin as a novel myokine. Int J Obes (Lond). 2014; 38(5):707-713.
Pekkala S, Wiklund PK, Hulmi JJ, Ahtiainen JP, Horttanainen M, Pöllänen E. Mäkelä KA. Are skeletal muscle FNDC5 gene expression and irisin release regulated by exercise and related to health?. The Journal of Physiology 2013; 591 (21): 5393 – 5400.
Moreno-Navarrete JM, Ortega F, Serrano M, Guerra E, Pardo G, Tinahones F, Ricart W, José MF. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. The Journal of Clinical Endocrinology & Metabolism 2013; 98(4): E769 – 778.
Shim YS, Kang MJ, Yang S, Hwang IT. Irisin is a biomarker for metabolic syndrome in prepubertal children. Endocr J. 2018; 65(1): 23-31.
Roca-Rivada A, Castelao C, Senin LL, Landrove MO, Baltar J, Crujeiras AB, Seoane LM, Casanueva FF, Pardo M. FNDC5/irisin is not only a myokine but also an adipokine. PLoS ONE 2013; 8(4): 1-10 e60563.
Ciloglu F, Ismail P, Aysel PJ, Kursat KM, Nevin IK, Ozcan SK, Recep OK, Yrd D. Exercise intensity and its effects on thyroid hormones. Neuroendocrinology Letters 2005; 26(6): 830-834.
Ruchala M, Zybek A, Szczepanek-Parulska E. Serum irisin levels and thyroid function--newly discovered association. Peptides 2014; 60: 51 – 55.
Bocco BM, Louzada RA, Silvestre DH, Santos MC, Anne-Palmer E, Rangel IF, Abdalla S, Ferreira AC, Ribeiro MO, Gereben B, Carvalho DP, Bianco AC, Werneck-de-Castro JP. Thyroid hormone activation by type 2 deiodinase mediates exercise-induced peroxisome proliferator-activated receptor- γ coactivator-1 α expression in skeletal muscle. J Physiol 2016; 594(18):5255-5269.
Staiger H, Böhm A, Scheler M, Berti L, Machann J, Schick F, Machicao F, Fritsche A, Stefan N, Weigert C, Krook A, Häring HU, de Angelis MH. Common genetic variation in the human FNDC5 locus, encoding the novelmuscle-derived 'browning' factor irisin, determines insulin sensitivity PLoS ONE 2013; 8(4): 1-10 e60562.
Feng X, Xia G, Yumei J, Zhang H, Qingrong P, Zhi Y, Ning Y. PPAR- α agonist fenofibrate decreased serum irisin levels in type 2 diabetes patients with hypertriglyceridemia. PPAR Research 2015.
Zhang Y, Li R, Meng Y, Li S, Donelan W, Zhao Y, Qi L. Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling. Diabetes 2014; 63(2): 514 – 525.
Højlund K, Boström P. Irisin in obesity and type 2 diabetes. Journal of Diabetes and Its Complications 2013; 27(4): 303 – 304.
de la Iglesia R, Lopez-Legarrea P, Crujeiras AB, Pardo M, Casanueva FF, Zulet MA, Martinez JA. Plasma irisin depletion under energy restriction is associated with improvements in lipid profile in metabolic syndrome patients. Clin. Endocrinol. (Oxf) 2014; 81(2):306-311.
Huh JY, Dincer F, Mesfum E, Mantzoros CS. Irisin stimulates muscle growth-related genes and regulates adipocyte differentiation and metabolism in humans. International Journal of Obesity 2014; 38(12): 1538 – 1544.
Wen, M.S., Wang, C.Y., Lin, S.L., Hung, K.C. 2013. Decrease in irisin in patients with chronic kidney disease. PLoS One 8(5): e64025.
Oelmann S, Nauck M, Völzke H, Bahls M, Friedrich N. Circulating irisin concentrations are associated with a favourable lipid profile in the general population. PLoS One 2016; 11(4):e0154319.
Published
How to Cite
Issue
Section
Copyright (c) 2018 Fathia Abd Elwahid Mannaa, Khaled G. Abdel-Wahhab, Ahmed Baha-Eldin Abdallah Elsayed, Maha Abdel-hamid fatehy, Ahmed Mohammed Shaker
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Innovations in Pharmaceutical and Biological Sciences is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at